$87.66
1.571.82%
At close: -
$87.02
-0.64-0.73%
After Hours: 5:12 PM EDT
Comments
Loading...
Blueprint Medicines Stock Guidance | NASDAQ:BPMC | Benzinga
Blueprint Medicines issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/05/2023 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $200.00M | $200.00M | $199.69M | Get Alert |
| 11/01/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $200.00M | $200.00M | $191.21M | Get Alert |
| 08/02/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $194.85M | Get Alert |
| 05/03/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $192.34M | Get Alert |
| 02/16/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $210.91M | Get Alert |
| 01/10/2022 | BPMC | Blueprint Medicines | FY | 2021 | — | — | — | $180.00M | $180.00M | $173.16M | Get Alert |
| 10/28/2021 | BPMC | Blueprint Medicines | FY | 2021 | — | — | — | $170.00M | $180.00M | $148.37M | Get Alert |
FAQ
What is the most recent guidance for Blueprint Medicines (BPMC)?
There have been no specific sales or earnings guidance reported for Blueprint Medicines in recent months.
Browse guidance and forecast on all stocks.
